Sarafian T A, Cheung M K, Verity M A
Neuropathol Appl Neurobiol. 1984 Mar-Apr;10(2):85-100. doi: 10.1111/j.1365-2990.1984.tb00342.x.
In an effort to characterize the principal mechanism(s) underlying the methyl mercury-induced defect in protein synthesis in vivo and in vitro, we examined the dose and time related effects of methyl mercury chloride (MeHg) on a variety of cellular functions using bulk-isolated neonatal cerebellar perikarya. This cell preparation demonstrated a high specific activity for protein synthesis which was optimal between 6 and 12 days of age and declined rapidly thereafter. In vitro MeHg inhibited synthesis with an ID50 of approximately 14 microM without causing significant release of lactate dehydrogenase. The inhibition of protein synthesis occurred independently of mercurial effects on RNA synthesis, mitochondrial function, ATP content or intracellular levels of Na+ and K+. Uptake of [3H]-phenylalanine was not appreciably affected by MeHg. The accumulated evidence suggests that in this in vitro cell model, MeHg inhibition of protein synthesis occurs via a direct interaction with the protein synthetic machinery.
为了确定甲基汞在体内和体外诱导蛋白质合成缺陷的主要机制,我们使用批量分离的新生小脑神经元胞体,研究了氯化甲基汞(MeHg)对多种细胞功能的剂量和时间相关影响。这种细胞制剂显示出较高的蛋白质合成比活性,在6至12日龄时最佳,此后迅速下降。在体外,MeHg抑制合成,ID50约为14 microM,且不会导致乳酸脱氢酶的显著释放。蛋白质合成的抑制独立于汞对RNA合成、线粒体功能、ATP含量或细胞内Na+和K+水平的影响。[3H] - 苯丙氨酸的摄取未受到MeHg的明显影响。累积的证据表明,在这个体外细胞模型中,MeHg对蛋白质合成的抑制是通过与蛋白质合成机制的直接相互作用发生的。